Filing Flows › Mannkind (MNKD) › Recalls, complaints & regulation
Mannkind (MNKD): clinical trials
Mannkind (MNKD) beyond its filings: 2 active clinical trials.
Mannkind's latest quarter
Mannkind, Q3 2026: revenue $102M (+24% year over year), operating margin -2.1%, net loss $23.2M, operating cash flow −$34.5M. The chart follows the revenue to costs, profit and cash.
Questions
How many clinical trials does Mannkind have?
2 active studies on ClinicalTrials.gov, 0 in phase 3.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.